Delivery Order SPE2DR25D2106-SPE2DR26F1FXR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,178.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This contract is unset-aside and represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,081.15 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count package) under a firm fixed price contract valued at $3,220.90. The award was issued on November 24, 2025, with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This contract was competitively awarded without any set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $35,913.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $5,071.03. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $4,993.87. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a contract ceiling value of $7,608.34 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,266.53 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,625.03 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FXRDelivery Order
The Defense Logistics Agency awarded a $3,375.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count configuration. The delivery order, which represents a non-set-aside competitive award, is scheduled for ultimate completion by December 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally, including products serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for ondansetron, a commonly used antiemetic medication, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/7/25 |